Results 31 to 40 of about 163,782 (212)

An unusual case of uterine PEComa presenting with disseminated intravascular coagulation

open access: yesGynecologic Oncology Reports, 2019
Perivascular epithelioid cell neoplasms (PEComas) are mesenchymal neoplasms originating from the perivascular epithelioid cell (PEC) line. The World Health Organization (WHO) further defines PEComa as “a mesenchymal tumor composed of histologically and ...
Rodger Rothenberger   +4 more
doaj   +1 more source

A Case of Malignant PEComa of the Uterus Associated with Intramural Leiomyoma and Endometrial Carcinoma [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2016
Perivascular epithelioid cell tumors (PEComas) refers to a family of mesenchymal neoplasms composed of angiomyolipomas, clear cell “sugar” tumors of the lung, and lymphangioleiomyomatoses.
Yoo Jin Choi   +4 more
doaj   +1 more source

Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis

open access: yesNature Communications, 2019
Uterine leiomyomata (UL) or fibroids are neoplasms of the uterine smooth muscle associated with heavy menstrual bleeding and other female reproductive tract morbidity.
C. S. Gallagher   +36 more
doaj   +1 more source

Carcinosarcoma of the uterus in a woman with Down syndrome

open access: yesHematology/Oncology and Stem Cell Therapy, 2010
There are only a few reports of uterine cancers in women with Down syndrome, whose tumor profile is marked by a reduced risk for solid neoplasms. There are no reports of a uterine carcinosarcoma arising in a woman with Down syndrome.
Ismail A. Al-Badawi   +2 more
doaj   +1 more source

Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients

open access: yesFrontiers in Oncology, 2023
ObjectivePatients with FIGO stage III endometrial cancer routinely receive adjuvant therapy. The purpose of this study was to evaluate overall survival (OS) and disease-free survival (DFS) in patients with stage IIIA to IIIC2 patients by treatment ...
Nora Tong   +6 more
doaj   +1 more source

Histopathology of Endometrial Stromal Sarcoma with Emphasis on Immunohistochemistry Marker Expression: Report of Three Cases

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth
Endometrial stromal tumors are rare uterine mesenchymal neoplasms. Endometrial stromal sarcomas (ESSs) are of endometrial stromal origin that accounts for approximately 1% of all uterine malignant neoplasms.
Narayanamoorthy Keerthyraj   +5 more
doaj   +1 more source

Intravenous caval leiomyomatosis in the setting of renal cell carcinoma – A case report

open access: yesUrology Case Reports, 2022
Uterine leiomyomas are common, benign neoplasms of the uterine smooth muscle. Leiomyomatosis is uncommon and causes development of multiple leiomyomas that can manifest as intravascular leiomyomatosis (IVL).
Brian Ceballos   +3 more
doaj   +1 more source

Uterine Mesenchymal Tumors: Updates on Pathology, Molecular Landscape, and Therapeutics

open access: yesMedicina
Background: Mesenchymal uterine tumors are a diverse group of neoplasms with varying biological potential. Many of these neoplasms can have overlapping morphologic similarities, which, in some instances, render their diagnosis and categorization thorough
Amal A. Alodaini
doaj   +1 more source

Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors [PDF]

open access: yes, 2018
Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant.
Codacci-Pisanelli, G   +4 more
core   +1 more source

Noninvasive Polypoid Malignant Mixed Mullerian Tumor of the Uterus: A Case Report and Literature Review

open access: yesAlbanian Journal of Trauma and Emergency Surgery
Introduction: Malignant mixed Müllerian tumors (MMMT), also known as carcinosarcomas, are rare and highly aggressive neoplasms of the uterus, accounting for less than 5% of all uterine malignancies.
Leon Kaza   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy